Variant Bio
Variant Bio is developing life-saving therapies by studying the genes of people with exceptional health-related traits. By identifying communities with unique genetic architectures and outlier phenotypes, Variant Bio has identified novel human genetic evidence that is the basis for programs with breakthrough potential across multiple therapeutic areas. The company's research is powered by its proprietary Inference platform, which integrates across deep phenotyping and multi-omic data using statistical genetics and AI/ML approaches to identify and validate therapeutic targets. In addition, Variant Bio has established strategic partnerships with Novo Nordisk and Boehringer Ingelheim, validating the strength of the platform and enabling the advancement of novel therapeutic programs through world-class development expertise. With ethics at its core, the company launched an unprecedented benefit-sharing program in 2020, in which it has pledged tangible benefits that directly impact the communities it partners with throughout the world.
Stellt Variant Bio ein?
Ja – Variant Bio hat aktuell 2 offene Stellen auf JobsRadar. Zuletzt aktualisiert am 6. September 2026 um 20:20 UTC.
Häufige Fragen
- Stellt Variant Bio ein?
- Ja. Variant Bio hat mit Stand 6. September 2026 2 offene Stellen auf JobsRadar.
- Für welche Bereiche stellt Variant Bio ein?
- Variant Bio stellt in den Bereichen Operations und Research Infrastructure ein.
- Wie aktuell sind diese Stellenanzeigen?
- Jede Anzeige stammt direkt aus dem Karriere-System des Arbeitgebers und wird dreimal täglich neu geprüft. Diese Seite wurde zuletzt am 6. September 2026 um 20:20 UTC aktualisiert.